Economic implications of the Total Ischaemic Burden Bisoprolol Study (TIBBS) follow-up

References

• Cannon PJ, Connell PA, Stockley IH, Garner ST, Hampton JR. Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet 1988; 1: 979–981.
   PubMed Web of Science ®Google Scholar
• Ghandi MM, Lampe F, Wood DA. Incidence of stable angina pectoris. Eur Heart J 1992; 13: 181
   Web of Science ®Google Scholar
• Gunnell D, Harvey I, Smith L. The invasive management of angina: issues for consumers and commissioners. J Epidemiol Community Health 1995; 49: 335–343.
   PubMed Web of Science ®Google Scholar
• Sagmeister M, Gessner U, Oggier W, Horisberger B, Gutzwilller F. An economic analysis of ischaemic heart disease in switzerland. Eur Heart J 1997; 18: 1102–1109.
   PubMed Web of Science ®Google Scholar
• Deedwania PC, Carbajal EV. Silent ischaemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990; 81: 748–756.
   PubMed Web of Science ®Google Scholar
• Pharoah P, Hollingworth W. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: a life table method applied to health authority population. BMJ 1996; 312: 1443–1448.
   PubMed Web of Science ®Google Scholar
• Kellett J. Cost-effectiveness of accelerated tissue plasminogen activator for acute myocardial infarction. Br J Medical Economics 1996; 10: 341–359.
   Google Scholar
• Caro J, Klittich W, McGuire A, et al. The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ 1997; 315: 1577–1582.
   PubMedGoogle Scholar
• Cleland JG. Can improved quality of care reduce the costs of managing angina pectoris? Eur Heart J 1996; 17 Suppl A: 29–40.
   Google Scholar
• TIBBS Investigators. Medical treatment to reduce total ischemic burden: Total Ischemic Burden Study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. JACC 1995; 25: 231–238.
   Google Scholar
• TIBBS Investigators. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis. Results of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up. JACC 1996; 28: 20–24.
   Google Scholar
• Mauskopf JA, Paul JE, Grant DM, Stergachis A. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 1998; 13: 277–288.
   PubMed Web of Science ®Google Scholar
• McMurray JJV, McGuire A, Davie AP, Hughes D. Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction. Eur Heart J 1997’; 18: 1411–1415.
   Google Scholar
• Monthly Index of Medical Specialties (MIMS). London: Haymarket Medical Ltd., 1996.
   Google Scholar
• British Medical Association RPSoGB. British national formulary. London: BMA and Pharmaceutical Press, 1996.
   Google Scholar
• McMurray J, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Medical Economics 1993; 6: 99–110.
   Google Scholar
• Byford S, Palmer S. Common errors and controversies in pharmacoeconomic analyses. Pharmacoeconomics 1998; 13: 659–666.
   PubMed Web of Science ®Google Scholar
• England and Wales Department of Health. Guidelines on good practice in the conduct of economic evaluation of medicines. London: Department of Health, 1994.
   Google Scholar
• Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990; 6: 57–75.
   PubMedGoogle Scholar
• Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the pharmaceutical benefits advisory committee: including major submissions involving economic analysis. Canberra: Australian Government Publishing Service, 1995.
   Google Scholar
• TreeAge Software, Inc. DATA (TM) 3.0 Users manual. Williamstown: TreeAge Software Inc., 1997.
   Google Scholar
• Kassier JP, Paulker SG. The toss-up. N Engl J Med 1981; 305: 1467–1469.
   PubMed Web of Science ®Google Scholar
• van den Brand M. Utilization of coronary angioplasty and cost of angioplasty disposables in 14 western European countries. European angioplasty survey group. Eur Heart J 1993; 14: 391–397.
   PubMed Web of Science ®Google Scholar
• OECD Health data 97 (CD ROM). 1997.
   Google Scholar
• Savonitto S, Ardissiono D, Egstrup K, et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international multicenter angina exercise (IMAGE) study. J Am Coll Cardiol 1996; 27: 311–316.
   PubMed Web of Science ®Google Scholar
• Dargie HJ, Ford I, Fox KM. Total ischaemic burden European trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET study group. Eur Heart J 1996; 17: 104–112.
   PubMed Web of Science ®Google Scholar
• Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The angina prognosis study in Stockholm (APSIS). Eur Heart J 1996; 17: 76–81.
   PubMed Web of Science ®Google Scholar
• Stone PH, Gibson RS, Glasser SP, et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS study group. Circulation 1990; 82: 1962–1972.
   PubMed Web of Science ®Google Scholar
• Ardissino D, Savonitto S, Egstrup K, et al. Selection of medical treatment in stable angina pectoris: results of the international multicenter angina exercise (IMAGE) study. J Am Coll Cardiol 1995; 25: 1516–1521.
   PubMed Web of Science ®Google Scholar
• Brown RKM, Halpern M. Cost analysis of once-daily ISMN versus twice-daily ISMN or transdermal patch for nitrate prophylaxis. Journal of Clinical Pharmacy and Therapeutics 1997; 22: 67–76.
   PubMed Web of Science ®Google Scholar
• Hubner P. Cardiac interventional procedures in the United Kingdom during 1991. Br Heart J 1993; 70: 201–203.
   PubMedGoogle Scholar
• Giec L. Choroba niedokrwienna serca. PZWL: Wydawn Lekarskie, 1996;
   Google Scholar